Vistagen Announces Topline Results for Repeat Dose Study of Fasedienol for Acute Treatment of Social Anxiety Disorder

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/18/2026

1. SPY
2. XENE
3. NUE
4. HUBS
5. RTB
6. ONON
7. AAPL
8. ACN
9. AZN
10. SPCX

Go back to Vistagen Announces Topline Results for Repeat Dose Study of Fasedienol for Acute Treatment of Social Anxiety Disorder
(NASDAQ: VTGN) Delayed: 0.24 +0.01 (4.35%)
Previous Close $0.23    52 Week High $4.60 
Open $0.23    52 Week Low $2.81 
Day High $0.25    P/E N/A 
Day Low $0.23    EPS $0.00 
Volume 718,462       

(NASDAQ: VTGN) Delayed: 0.24 +0.01 (4.35%)
Previous Close $0.23    52 Week High $4.60 
Open $0.23    52 Week Low $2.81 
Day High $0.25    P/E N/A 
Day Low $0.23    EPS $0.00 
Volume 718,462